ISSN: 1735-1308
Instant 2021
The prevalence of renal stone and outcomes of conservative treatment in kidney transplantation: A systematic review and meta-analysis
Urology Journal,
,
23 February 2021
,
Page 6531
https://doi.org/10.22037/uj.v18i02.6531
Abstract
BackgroundNephrolithiasis is a rare complication in transplanted kidneys and limited information is available about its therapeutic options. This study aimed to review the conservative management of urinary lithiasis and its outcomes in renal transplanted patients.
Methods
A systematic review and meta-analysis of the scientific literature were performed in the Medline, Scopus, and Embase databases. Inclusion criteria were studies which include patients with kidney stones in transplanted kidney no matter de-novo or donated stones and use conservative treatment for all or part of their patients. Exclusion criteria were bladder & ureteral stones, full text unavailable, conference paper. (from January 1st, 1980, to the 19th May 2020). The results of included studies, in the final analysis, were combined using a random-effect model and using metaprop method prevalence and 95% CI of renal stone were reported.
Results
A total of 8 studies (14988 transplant patients) met the inclusion criteria for the final analysis. A total of 195 patients suffered from renal stone and the prevalence of renal stone was 1.3% (95% CI: 0.89% - 1.7%). The mean age of these patients was 43 years. analysis, the prevalence of conservative treatment in 195 patients was 35% (95% CI: 19%-51%). The mean stone size ranged from 0.29 cm to 1 cm. Three studies reported a stone-free rate of %100. Except for two studies that did not report complications, other studies reported zero percent.
Conclusion
More than one-third of nephrolithiasis were conservatively managed in transplanted patients. Despite limited data, conservative treatment could be done in less than 4 mm stones with high Stone Free Rate (SFR) and very low complications.
- Kidney Transplantation, Kidney Calculi, Nephrolithiasis, conservative treatment
How to Cite
References
2. Challacombe B, Dasgupta P, Tiptaft R, Glass J, Koffman G, Goldsmith D, et al. Multimodal management of urolithiasis in renal transplantation. BJU international. 2005;96(3):385-9.
3. Stravodimos KG, Adamis S, Tyritzis S, Georgios Z, Constantinides CA. Renal transplant lithiasis: analysis of our series and review of the literature. Journal of endourology. 2012;26(1):38-44.
4. Emiliani E, Subiela JD, Regis F, Angerri O, Palou J. Over 30-yr Experience on the Management of Graft Stones After Renal Transplantation. European urology focus. 2018;4(2):169-74.
5. Palazzo S, Colamonico O, Forte S, Matera M, Lucarelli G, Ditonno P, et al. Experience of percutaneous access under ultrasound guidance in renal transplant patients with allograft lithiasis. Archivio Italiano di Urologia e Andrologia. 2016;88(4):337-40.
6. Sarier M, Duman I, Yuksel Y, Tekin S, Demir M, Arslan F, et al. Results of minimally invasive surgical treatment of allograft lithiasis in live-donor renal transplant recipients: a single-center experience of 3758 renal transplantations. Urolithiasis. 2019;47(3):273-8.
7. Cicerello E, Merlo F, Mangano M, Cova G, Maccatrozzo L. Urolithiasis in renal transplantation: diagnosis and management. Archivio Italiano di Urologia e Andrologia. 2014;86(4):257-60.
8. Sha-dan L, Qing-tang W, Wei-guo C. Treatment of urinary lithiasis following kidney transplantation with extracorporeal shock-wave lithotripsy. Chinese medical journal. 2011;124(9):1431-4.
9. Devasia A, Chacko N, Gnanaraj L, Cherian R, Gopalakrishnan G. Stone-bearing live-donor kidneys for transplantation. BJU Int. 2005;95(3):394-7.
10. Harraz AM, Zahran MH, Kamal AI, El-Hefnawy AS, Osman Y, Soliman SA, et al. Contemporary Management of Renal Transplant Recipients With De Novo Urolithiasis: A Single Institution Experience and Review of the Literature. Exp Clin Transplant. 2017;15(3):277-81.
11. Lancina Martín JA, García Buitrón JM, Díaz Bermúdez J, Alvarez Castelo L, Duarte Novo J, Sánchez Merino JM, et al. [Urinary lithiasis in transplanted kidney]. Arch Esp Urol. 1997;50(2):141-50.
12. Verrier C, Bessede T, Hajj P, Aoubid L, Eschwege P, Benoit G. Decrease in and management of urolithiasis after kidney transplantation. Journal of Urology. 2012;187(5):1651-5.
13. Xing L, Jiang X, Wang ZP, Miao SZ, Qu QS. Uric acid nephrolithiasis after renal transplantation. Chinese Journal of Tissue Engineering Research. 2012;16(40):7433-7.
14. Yuan HJ, Yang DD, Cui YS, Men CP, Gao ZL, Shi L, et al. Minimally invasive treatment of renal transplant nephrolithiasis. World Journal of Urology. 2015;33(12):2079-85.
15. Sarier M, Duman I, Callioglu M, Soylu A, Tekin S, Turan E, et al. Outcomes of Conservative Management of Asymptomatic Live Donor Kidney Stones. Urology. 2018;118:43-6.
16. Cheungpasitporn W, Thongprayoon C, Mao MA, Kittanamongkolchai W, Jaffer Sathick IJ, Dhondup T, et al. Incidence of kidney stones in kidney transplant recipients: A systematic review and meta-analysis. World J Transplant. 2016;6(4):790-7.
17. Ganpule A, Vyas JB, Sheladia C, Mishra S, Ganpule SA, Sabnis R, et al. Management of urolithiasis in live-related kidney donors. Journal of endourology. 2013;27(2):245-50.
18. C. Türk AN, A. Petrik, C. Seitz, A. Skolarikos , K. Thomas, N.F. Davis, J.F. Donaldson, R. Lombardo, N. Grivas, Y. Ruhayel. EAU guidelines urolithiasis2019. Available from: https://uroweb.org/guideline/urolithiasis/.
19. Alan W. Partin CAP, Louis R. Kavoussi, Roger R. Dmochowski, Alan J. Wein. Campbell Walsh Urology. 11 ed2016. 4906 p.
20. Alan W. Partin CAP, Louis R. Kavoussi, Roger R. Dmochowski, Alan J. Wein. Campbell Walsh Wein Urology. 12 ed2020. 4096 p.
21. Harraz AM, Kamal AI, Shokeir AA. Urolithiasis in renal transplant donors and recipients: An update. International Journal of Surgery. 2016;36:693-7.
22. Emiliani E, Subiela JD, Regis F, Angerri O, Palou J. Over 30-yr Experience on the Management of Graft Stones After Renal Transplantation. Eur Urol Focus. 2018;4(2):169-74.
- Abstract Viewed: 0 times
- Just Accepted/6531 Downloaded: 0 times
